Above all, we make a difference.

2019-2020 Public Policy & Advocacy Priorities

Every two years, Komen identifies the advocacy issues where Komen’s voice could provide the greatest potential impact on achieving our Bold Goal. A broad-based, intensive vetting and selection process includes feedback from Affiliates, representatives from the African-American Health Equity Initiative (AAHEI), metastatic breast cancer community, Advocates in Science (AIS), Komen Scholars and subject matter experts. The following issues form the basis for Komen’s state and federal public policy and advocacy work through 2020.

Komen’s 2019 – 2020 Public Policy & Advocacy Priorities:

Ensure Access to Affordable, High-Quality Health Care

  • Protect access to affordable, high-quality health care for all patients.
  • Support Medicaid expansion and expanded eligibility for Medicaid’s Breast and Cervical Cancer Treatment Program (BCCTP).
  • Ensure continued access to Medicaid coverage without burdensome restrictions.

Advance Breast Cancer Research

  • Expand federal funding for all biomedical research, especially breast cancer research conducted at the National Institutes of Health (NIH) and at the Department of Defense (DOD).
  • Support state funding for breast cancer research programs conducted through state institutions.
  • Support increased education, utilization of and access to clinical trials for all patient populations.

Increase Coverage and Access to Breast Cancer Screening and Diagnostic Services

  • Support federal and state funding for the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
  • Support policies to modernize NBCCEDP state programs to expand eligibility and provide breast cancer screening and diagnostic services for additional populations.
  • Reduce or eliminate out-of-pocket costs for diagnostic imaging.

Reduce Insurance Barriers to Treatment

  • Protect patient preference and enhance coverage, including policies that would require oral parity, preclude specialty tiers, prevent step therapy protocols, prevent non-medical switching and limit patients’ out-of-pocket costs.


To share your story or for additional information, please contact us at policy@komen.org.




Stay updated with advocacy news and alerts.

Get Involved